07U307Z
Supplement Lymphatic, Right Upper Extremity to No Qualifier with Autologous Tissue Substitute, Open Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 7 Lymphatic and Hemic Systems |
| Operation | U Supplement |
| Body Part | 3 Lymphatic, Right Upper Extremity |
| Approach | 0 Open |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
This family covers procedures where a surgeon places biological or synthetic material onto or into a structure of the lymphatic and hemic system to reinforce it or bolster a function that has been weakened, most often after injury. The leading example is splenic salvage surgery: when the spleen has been lacerated in blunt abdominal trauma, wrapping it in absorbable mesh compresses the injured tissue and supports it while it heals, allowing the surgeon to avoid removing the organ altogether. Patients benefit because the spleen filters blood and helps fight certain bacteria, so keeping it intact lowers the lifetime risk of severe infection that follows a splenectomy.
The material itself is not doing the healing directly; it is holding tissue together and adding structural support so that the body's own repair processes can proceed without the organ falling apart or re-bleeding. Outside of splenic trauma, this family sees limited use elsewhere in the lymphatic system, since lymph nodes and channels are rarely reinforced with an implanted product.
Anatomy & Axis Detail
Lymphatic, Right Upper Extremity
Lymphatic vessels and nodes of the right upper extremity drain the right arm and hand, converging toward the axillary nodes, and are commonly disrupted after axillary node dissection or radiation for breast cancer, resulting in arm lymphedema. Supplement addresses this by reinforcing the compromised lymphatic pathway, most often through vascularized lymph node transfer or grafting techniques intended to restore functional drainage in a limb where native tissue remains but is insufficient. Because chronic arm swelling significantly affects daily function and quality of life, these reconstructive procedures have become more common alongside conventional lymphedema management. The documentation should reflect that the existing right arm lymphatic structures were retained and physically supplemented with additional material, which separates this coding choice from a full excision and replacement approach.
Approach: Open
Open approach means the surgeon cuts through skin, mucous membrane, or other tissue layers to physically expose the target site to view before performing the procedure. It gives direct visualization and hands-on access, distinguishing it from Percutaneous approaches where instruments pass through a small puncture without exposing the site. Open is typical for procedures needing wide access, such as most laparotomies.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
A coder should look for documentation that a mesh, wrap, or similar reinforcing material was left in place around an existing structure, most commonly the spleen, distinguishing it from a laceration that was simply sutured closed. The operative note needs to specify both the material used and that it augments rather than replaces the organ. The most frequent error is defaulting to Repair whenever a splenic injury is fixed surgically, when the presence of a retained mesh wrap actually calls for Supplement with the correct device value recorded.